Newsroom
Sorted by: Latest
-
Advanced Drainage Systems Announces Quarterly Cash Dividend
HILLIARD, Ohio--(BUSINESS WIRE)--Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading provider of innovative water management solutions in the stormwater and onsite wastewater industries, today announced that its Board of Directors (the “Board”) has approved a quarterly cash dividend to its shareholders in the amount of $0.20 per share, a 11% increase over the prior year dividend amount.Scott Barbour, President and Chief Executive Officer of Advanced Drainage Systems c...
-
Advanced Drainage Systems Announces Second Quarter Fiscal 2027 Results
HILLIARD, Ohio--(BUSINESS WIRE)--Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading provider of innovative water management solutions in the stormwater and onsite wastewater industries today announced financial results for the fiscal second quarter ended September 30, 2026. Scott Barbour, President and Chief Executive Officer of ADS commented, "Our second quarter results demonstrate the resilience of our business model and the team's ability to execute in a challeng...
-
SS&C Announces Pricing of Upsized Offering of $1.05 Billion of 2.75% Convertible Senior Notes Due 2031
WINDSOR, Conn.--(BUSINESS WIRE)--SS&C Announces Pricing of Upsized Offering of $1.05 Billion of 2.75% Convertible Senior Notes Due 2031...
-
Henry Schein to Participate in Upcoming Investor Conferences in November and December
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November and December: Jefferies Healthcare Conference at the Waldorf Hilton, London on November 17, 2026, at 9:00 a.m. Greenwich Time/4:00 a.m. Eastern time. Piper Sandler’s Healthcare Conference at the Lotte New York Palace Hotel, New York...
-
InfuSystem Announces Financial Results for Third Quarter 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Financial Results for Third Quarter 2026...
-
Cresco Labs Advances Innovation Pipeline with High Supply SLIPS and Wonder THC Drink Mixes
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (“Cresco Labs” or the “Company”), today announced two new additions to its portfolio of leading cannabis brands: High Supply SLIPS—fast-acting oral THC pouches—and Wonder THC Drink Mixes—single-serving beverage packets. The launches reflect the Company's focus on identifying unmet consumer needs, creating new consumer occasions, and developing products that bring new audiences into the regulated cannabis market. “In addition to...
-
Strategic Education, Inc. Reports Third Quarter 2026 Results
HERNDON, Va.--(BUSINESS WIRE)--Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced financial results for the period ended September 30, 2026. STRATEGIC EDUCATION CONSOLIDATED RESULTS Three Months Ended September 30 Revenue increased 1.6% to $325.1 million compared to $319.9 million for the same period in 2025, driven by strength within the Education Technology Services segment, an increase in U.S. Higher Education segment revenue per student, and favorable foreign cur...
-
NCR Voyix Reports Third Quarter 2026 Results
ATLANTA--(BUSINESS WIRE)--NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or the “Company”), a platform-powered leader in unified commerce for shopping and dining, reported financial results today for the three and nine months ended September 30, 2026. Third Quarter Financial Highlights Revenue was $539 million compared to $677 million in the prior year period, which reflects the impact of the Hardware Business Transition. Software and services revenue was $500 million compared to $500 million i...
-
Armada Acquisition Corp. III and Brains Bioceutical Corp. Announce Business Combination to Advance a Global Life Sciences and Pharmaceutical Innovation Platform
PHILADELPHIA & VANCOUVER, British Columbia--(BUSINESS WIRE)--Armada Acquisition Corp. III (Nasdaq:AACI) (“Armada III”), a publicly traded special purpose acquisition company, and Brains Bioceutical Corp. (“Brains” or the “Company”), an integrated life sciences and pharmaceutical company specializing in active pharmaceutical ingredient (“API”) manufacturing and supply, pharmaceutical research and drug development, today announced that they have entered into a definitive business combination agree...
-
Vontier Reports Strong Third Quarter Results and Raises Full Year Adjusted EPS Guidance
RALEIGH, N.C.--(BUSINESS WIRE)--Vontier Reports Strong Third Quarter Results and Raises Full Year Adjusted EPS Guidance...